Spegra (Dolutegravir/Emtricitabine/Tenofovir Alafenamide)

Introduction:

Spegra is a fixed-dose combination tablet that includes three antiretroviral medicines: Dolutegravir, Emtricitabine, and Tenofovir alafenamide. The combination is utilized in the treatment of the Human Immunodeficiency Virus (HIV) infection in adults and children (weighing more than 35kg). Utilizing three drugs with distinct mechanisms of action, Spegra provides a powerful, simple program to HIV treatment that focuses on maintaining the suppression of HIV.

Spegra is a great option for those who are starting HIV therapy or who are switching to other regimens due to its single-tablet treatment that is a breeze for managing HIV.

Mechanism of Action:

• Dolutegravir (Integrase Inhibitor): Dolutegravir acts by blocking the HIV-1 integrase enzyme vital for the introduction of viral DNA into the host’s DNA. By preventing this action, Dolutegravir can reduce the spread of the virus within the body.
• Emtricitabine (Nucleoside Reverse Transcriptase Inhibitor – NRTI): Emtricitabine blocks the reverse transcriptase enzyme, which is required to convert the viral DNA into. In this way, it blocks the viral replication.
• Tenofovir Alafenamide (Nucleotide Reverse Transcriptase Inhibitor – NRTI): Tenofovir Alafenamide is an antidepressant that transforms to Tenofovir in the body. It also inhibits the reverse transcriptase enzyme and blocks HIV replication.

Through combining three different mechanisms of effectiveness, Spegra provides highly effective treatment of HIV.

Indications and Usage:

Spegra is recommended for the treatment of HIV-1 infections in the following areas:

• Adults and pediatric patients weigh less than 35kg, who have not received treatment or have been suppressed virologically with stable antiretroviral treatment.
• Post-exposure prophylaxis (PEP): If the situation is right, Spegra can be used to treat PEP. However, it should be supervised by a medical professional.

It’s not recommended for patients suffering from HIV-2 disease.

Dosage and Administration:

Spegra is a prescription medication. Spegra is:

• 1 tablet every day, whether or not with food.

Spegra is best taken throughout the day to ensure consistent blood levels of the drug. It is essential to take the tablet in its entirety and not to smash, break, or chew it.

Special Populations:

• Renal Impairment: If you have a patient suffering from moderate or severe kidney impairment (CrCl < 30mL/min), a dose adjustment could be necessary. Spegra might not be appropriate for patients suffering from kidney disease in the end stage of dialysis.
• Hepatic Impairment: Patients suffering from severe or moderate hepatic impairments should take Spegra carefully and only with medical supervision.

Contraindications:

Spegra is not recommended in the following circumstances:

• Hypersensitivity to any of the components (Dolutegravir, Emtricitabine, or Tenofovir Alafenamide).
• Severe Hepatic Impairment: In light of the possibility of the liver’s function declining, people who suffer from severe liver diseases must stay clear of Spegra.
• Co-administration with Certain Drugs: Beware of co-administration with other drugs such as dofetilide or rifampin as well as st. John’s Wort, since they may interact with each other and alter the efficiency of Spegra.

Warnings and Precautions:

• Liver Toxicity: The monitoring of liver function is vital, especially during the beginning phases of treatment. Patients suffering from pre-existing liver disease that is pre-existing need to be closely monitored.
• Renal Function: Monitoring of kidney function regularly (serum creatinine and EGF) is advised, since Tenofovir Alafenamide could result in kidney damage.
• HIV Resistance: If treatment begins using an ineffective treatment or when patients have a problem complying, there is a higher risk of becoming resistant to drugs, and HIV strains rise.
• Lactic Acidosis and Hepatomegaly: While rare, lactic acidosis and hepatomegaly (with the presence of steatosis) are severe conditions that may occur in conjunction in the context of antiretroviral treatment, specifically the NRTIs Emtricitabine as well as Tenofovir. The immediate discontinuation of treatment is required if signs of lactic acidosis develop.
• Pregnancy and Breastfeeding: The security of Spegra during pregnancy isn’t completely established. Therefore, it is only recommended to use it in cases where the benefits are greater than the risks. It’s not advised to be used in women who are breastfeeding because of the possibility of passing the virus on to the baby.

Side Effects:

The most common side effects associated with Spegra are:

• Diarrhea: Common gastrointestinal complaints can be treated early.
• Nausea and Vomiting: The occasional stomach ache can happen, especially in the initial couple of weeks after the treatment.
• Fatigue: You’re feeling tired and weak.
• Headache: A few patients complain of headaches after the initial treatment.
• Insomnia: Trouble sleeping can be a result.
• Rash: Mild skin rashes can develop.

More serious, but less frequent reactions may include:

• Liver Issues: Hepatitis, liver enzyme elevations, or jaundice.
• Kidney Toxicity: The serum creatinine level is increased, or there are changes in tests for kidney function.
• Psychiatric Symptoms: A few patients have had suicidal or depression-related thoughts, especially those who have a previous history of mental health problems.
• Immune Reconstitution Syndrome: Inflammatory response in illnesses or infections that were previously not diagnosed in the first few days of antiretroviral treatment.

Drug Interactions:

• Drugs that Induce UGT1A1 Enzyme: The use of medications such as rifampin or St. John’s Wort may decrease the efficacy of Dolutegravir for Spegra.
• Antacids, Proton Pump Inhibitors (PPIs), and H2 Blockers: These drugs can hinder the absorption of Dolutegravir. If administered together, break you’re dosing over a period of time.
• Other HIV Medications: It is recommended to be cautious in conjunction with Spegra, together with other HIV treatments.

Storage:

• Store Spegra tablets at room temperature (between 20°C to 25°C or 68°F to 77°F).
• Store the medication in the original container to shield it from moisture.
• Stay out of the child’s reach.

Frequently Asked Questions (FAQs):

How should I take Spegra?

Consume 1 tablet of Spegra every day, either without or with food, preferring to do it at the same time every day. Avoid breaking, crushing, or chewing the tablet.

Can Spegra be used in children?

Spegra is safe for children with a weight of at least 35kg who meet the guidelines to be eligible for HIV treatment. Consult a pediatric physician for a treatment program that is appropriate.

What should I do if I miss a dose of Spegra?

If you don’t remember a dose, get the dose as soon as you remember, or until you’re nearing the time to take your next dose. Do not take more than two doses in one go in order to cover the missed dose.

Can I take Spegra with food?

Yes, Absolutely, Spegra is a medicine that can be used either with or without food. However, taking it along with food could help lessen adverse effects on the gastrointestinal tract.

Is Spegra safe during pregnancy?

Spegra is not recommended when pregnant unless it is clearly necessary. Talk to your doctor to evaluate the risks and the benefits.

How long will I need to take Spegra?

HIV treatment typically lasts for life. Talk to your doctor regarding your personal treatment plan.

What are the common side effects of Spegra?

Common side effects are nausea, vomiting, diarrhea, and headaches. Many side effects fade with time. If they continue or grow serious, speak to your physician.

Can I drink alcohol while taking Spegra?

Moderate drinking of alcohol will not cause any serious interactions. However, overconsumption can cause liver harm, particularly when paired with antiretroviral medication.

Summary:

Spegra is a mixture of potent antiretroviral medicines that are potent: Dolutegravir, Emtricitabine, and Tenofovir Alafenamide are a treatment for HIV-1. It streamlines treatment by offering an all-day, single-tablet treatment, which makes it simpler for patients to stick to their regimen. Spegra is tolerated by the majority of patients. However, the most frequent side effects are gastrointestinal problems as well as fatigue. It is essential to keep track of the function of the kidneys and the liver while using this medicine. Regular follow-ups with health professionals can be vital to improve HIV treatment and to prevent the progression of drug resistance.